Adeza to Present at the Roth Capital Partners 18th Annual Growth Stock Conference; Webcast Scheduled February 21 at 12:00 p.m. E
15 Febrero 2006 - 3:00AM
Business Wire
Adeza (NASDAQ: ADZA) today announced that Emory V. Anderson,
president and chief executive officer, will make an investment
community presentation at the Roth Capital Partners 18th Annual
Growth Stock Conference on Tuesday, February 21 at 12:00 p.m.
Eastern Time (9:00 a.m. Pacific Time). The conference is being held
at the St. Regis Monarch Beach Resort & Spa in Dana Point,
Calif. A live audio and slide webcast of the presentation will be
available via the Internet by visiting the Investors section of the
company's Web site at www.adeza.com. An archived presentation will
be available on the Web site for 14 days. Adeza designs,
manufactures and markets innovative products for women's health.
Adeza's initial focus is on reproductive healthcare, using its
proprietary technologies to predict preterm birth and assess
infertility. Adeza's principal product is a patented diagnostic
test, FullTerm(R), The Fetal Fibronectin Test, which utilizes a
single-use, disposable cassette and is analyzed on Adeza's patented
TLiIQ(R) System. This product is approved by the U.S. Food and Drug
Administration (FDA) for use in assessing the risk of preterm
birth. Adeza also markets and sells the E-tegrity(R) Test, an
infertility-related test to assess receptivity of the uterus to
embryo implantation in women with unexplained infertility. More
information is available at www.adeza.com. Adeza cautions you that
statements included in this press release that are not a
description of historical facts may be forward-looking statements.
The inclusion of forward-looking statements should not be regarded
as a representation by Adeza that any of its plans will be
achieved. Actual results may differ materially from those set forth
in this release due to the risks and uncertainties inherent in
Adeza's business including, without limitation, statements about
the expansion of the indications for its products. All
forward-looking statements are qualified in their entirety by this
cautionary statement and Adeza undertakes no obligation to revise
or update this news release to reflect events or circumstances
after the date hereof.
Adeza (NASDAQ:ADZA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Adeza (NASDAQ:ADZA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Adeza Biomedical (MM) (NASDAQ): 0 recent articles
Más de Adeza Artículos de Noticias